1. J.A. Witjes, E. Compérat, N.C. Cowan, M. De Santis, G. Gakis, T. Lebrét, M.J. Ribal, A. Sherif, A.G. van der Heijden; members of the European Association of Urology (EAU) Guidelines Office. Guidelines on Muscle- Invasive and Metastatic Bladder Cancer. In: EAU Guidelines, edition presented at the 29th EAU Annual Congress, Vienna 2014. ISBN 978-90-79754-71-7, EAU Guidelines Office, Arnhem, The Netherlands.
2. Bagnato A, Rosanò L. The endothelin axis in cancer. Int J Biochem Cell Biol. 2008;40(8):1443–51.
3. Herrmann E, Bögemann M, Brierer S, et al. The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications. Expert Rev Anticancer Ther. 2006;6(1):73–81.
4. Wülfing C, Eltze E, Piechota H, et al. Expression of endothelin-1 and endothelin-A and -B receptors in invasive bladder cancer. Oncol Rep. 2005;13(2):223–8.
5. Soloway M, Khoury S. Bladder cancer: 2nd International Consultation on Bladder Cancer—Vienna. ISBN: 978-9953-493-20-6. European Association of Urology (EAU) and International Consultation on Urological Diseases (ICUD), Second edition, Paris, France 2012.